Corporate GovernanceJun 4, 2026, 05:31 PM
Veea Inc. Faces Nasdaq Governance Non-Compliance After Director's Death
AI Summary
Veea Inc. has notified Nasdaq that it is no longer in compliance with independent director requirements for its Board of Directors, audit committee, and compensation committee following the unexpected passing of a director. Nasdaq has provided a cure period until May 31, 2027, or potentially sooner, for the company to regain compliance. Veea intends to take necessary actions to meet these requirements.
Key Highlights
- Veea Inc. notified Nasdaq of non-compliance with majority independent director requirement due to a director's passing.
- The company is also non-compliant with independent director requirements for its audit and compensation committees.
- Nasdaq has granted a cure period until the earlier of the next Annual Meeting or May 31, 2027, with a potential earlier deadline of November 27, 2026.
- The company intends to take actions to regain compliance within the specified cure periods.
Price Impact
More from VEEA